We have located links that may give you full text access.
Prevalence of keratoconus among patients seeking laser vision correction in Taif area of Saudi Arabia.
Purpose: To determine the prevalence of keratoconus among patients seeking laser vision correction (LVC).
Methods: Retrospective study of 1374 eyes of 687 patients (335 males, 352 females) who underwent keratoconus screening as a part of routine preoperative evaluation prior to LVC at the Tadawi surgical centre, Taif, Saudi Arabia from January 2014 to June 2015. The diagnosis of keratoconus was based on evaluation of Pentacam derived parameters.
Results: Manifest keratoconus was found in 59 subjects (out of 687 subjects) representing a prevalence rate of 8.59%. Of the 687 subjects, 45 subjects (6.55%) had bilateral manifest keratoconus (manifest keratoconus in both eyes or manifest keratoconus in one eyes and sub-clinical in contralateral eye) and remaining 14 patients (2.04%) had unilateral manifest keratoconus (with normal fellow eye). Sub-clinical keratoconus was diagnosed in 65 patients representing a prevalence rate of 9.46%. Of the 687 patients, 20 cases (2.91%) with subclinical keratoconus were bilateral and 45 (6.55%) were unilateral. Overall, 19.70% males (66/335) and 16.48% (58/352) females had either manifest or sub-clinical keratoconus, representing no statistically significant difference in the gender predisposition of the keratoconus disease process (Chi Square test; p = .277).
Conclusion: High prevalence of keratoconus was found among patients seeking LVC. Possible factors contributing to the high prevalence were recognized to be highly selective population (patients seeking LVC for myopia/hyperopia/astigmatism), ethnicity (high prevalence of consanguinity) and geographical location (high altitude) of the study subjects.
Methods: Retrospective study of 1374 eyes of 687 patients (335 males, 352 females) who underwent keratoconus screening as a part of routine preoperative evaluation prior to LVC at the Tadawi surgical centre, Taif, Saudi Arabia from January 2014 to June 2015. The diagnosis of keratoconus was based on evaluation of Pentacam derived parameters.
Results: Manifest keratoconus was found in 59 subjects (out of 687 subjects) representing a prevalence rate of 8.59%. Of the 687 subjects, 45 subjects (6.55%) had bilateral manifest keratoconus (manifest keratoconus in both eyes or manifest keratoconus in one eyes and sub-clinical in contralateral eye) and remaining 14 patients (2.04%) had unilateral manifest keratoconus (with normal fellow eye). Sub-clinical keratoconus was diagnosed in 65 patients representing a prevalence rate of 9.46%. Of the 687 patients, 20 cases (2.91%) with subclinical keratoconus were bilateral and 45 (6.55%) were unilateral. Overall, 19.70% males (66/335) and 16.48% (58/352) females had either manifest or sub-clinical keratoconus, representing no statistically significant difference in the gender predisposition of the keratoconus disease process (Chi Square test; p = .277).
Conclusion: High prevalence of keratoconus was found among patients seeking LVC. Possible factors contributing to the high prevalence were recognized to be highly selective population (patients seeking LVC for myopia/hyperopia/astigmatism), ethnicity (high prevalence of consanguinity) and geographical location (high altitude) of the study subjects.
Full text links
Related Resources
Trending Papers
Executive Summary: State-of-the-Art Review: Unintended Consequences: Risk of Opportunistic Infections Associated with Long-term Glucocorticoid Therapies in Adults.Clinical Infectious Diseases 2024 April 11
Autoimmune Hemolytic Anemias: Classifications, Pathophysiology, Diagnoses and Management.International Journal of Molecular Sciences 2024 April 13
Clinical practice guidelines on the management of status epilepticus in adults: A systematic review.Epilepsia 2024 April 13
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app